Action AbSci - ABSI

AbSci Corporation (ABSI) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

10,6761

( -6,92% )

Prix Achat

10,63

Prix Vente

10,68

Volume échangé

4 696 825

Volume moyen (3 m)

US$ 5 933 342

Volume financier

US$ 50 172 316

10,32 Fourchette du Jour 11,4124

2,24 Plage de 52 semaines 12,055

Cap du marché

1,809B

Valeur d'Entreprise

1,847B

Clôture Veille

11,47

Ouverture

11,37

Dernière Transaction

10.67

Dernière heure de transaction

VWAP

10,6822

Chiffre d'affairess (LTM)

1,84M

Bénéfice net (LTM)

-118,44M

Actions en circulation

169 400 333

Flottant (%)

95,46%

Détention Institutionnelle (%)

78,90%

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-14,12

Ratio Cours/Ventes (P/S)

1,07k

Bénéfice par action (BPA)

-0,82

Bêta

2,33

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (P... Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington. Show more

Secteur

Health Care

Industrie

Site Web

www.absci.com

Siège social

Vancouver, United States

Fondé

2026

AbSci Corporation est coté dans le secteur Health Care de la NASDAQ avec le ticker ABSI. Le dernier cours de clôture d'AbSci était de US$11,47. Au cours de la dernière année, les actions de AbSci ont été négociées dans une fourchette de prix de US$ 2,24 à US$ 12,055.

AbSci compte actuellement 169 400 333 actions en circulation. La capitalisation boursière d'AbSci est de US$1,81 milliard. AbSci a un ratio cours/bénéfice (ratio PE) de -14.12.

Flux global

Haussier

Prime nette

3M

Calls / Puts

100,00%

Ach. / Vent.

183,33%

OTM / ITM

21,43%

Sweeps Ratio

0,00%

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.9539	-8.20206362855	11.63	12	10.4	5297916	11.34551855	CS
4	4.0761	61.7590909091	6.6	12.055	6.362	8581184	9.79109998	CS
12	7.3461	220.603603604	3.33	12.055	3.33	6283333	7.31958447	CS
26	7.3061	216.798219585	3.37	12.055	2.24	4796050	5.56924033	CS
52	7.8261	274.6	2.85	12.055	2.24	4981319	4.36285371	CS
156	9.1161	584.365384615	1.56	12.055	1.1111	2966013	4.00623295	CS
260	-10.3239	-49.1614285714	21	31.5301	1.1111	2023552	4.23463137	CS

ABSI - Frequently Asked Questions (FAQ)

What is the current AbSci Corporation share price?

The current share price of AbSci Corporation is US$ 10,6761

How many AbSci Corporation shares are in issue?

AbSci Corporation has 169 400 333 shares in issue

What is the market cap of AbSci Corporation?

The market capitalisation of AbSci Corporation is USD 1,81B

What is the 1 year trading range for AbSci Corporation share price?

AbSci Corporation has traded in the range of US$ 2,24 to US$ 12,055 during the past year

What is the PE ratio of AbSci Corporation?

The price to earnings ratio of AbSci Corporation is -14,12

What is the cash to sales ratio of AbSci Corporation?

The cash to sales ratio of AbSci Corporation is 1,07k

What is the registered address of AbSci Corporation?

The registered address for AbSci Corporation is 18105 SE Mill Plain Boulevard, Vancouver, Washington, 98683

What is the AbSci Corporation website address?

The website address for AbSci Corporation is www.absci.com

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AbSci Corporation (ABSI)

AbSci Corporation (ABSI) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de AbSci Corporation

Flux d'options AbSci (ABSI)

Flux global

Haussier

Prime nette

3M

Calls / Puts

100,00%

Ach. / Vent.

183,33%

OTM / ITM

21,43%

Sweeps Ratio

0,00%

ABSI Dernières nouvelles

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI)

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

Form 8-K - Current report

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI)

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

Form 8-K - Current report

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

ABSI - Frequently Asked Questions (FAQ)

ABSI Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités